111 related articles for article (PubMed ID: 3221260)
1. Selective retention of rhodamine-123 by malignant glioma in the rat.
Powers SK; Ellington K
J Neurooncol; 1988 Dec; 6(4):343-7. PubMed ID: 3221260
[TBL] [Abstract][Full Text] [Related]
2. Interstitial laser photochemotherapy of rhodamine-123-sensitized rat glioma.
Powers SK; Beckman WC; Brown JT; Kolpack LC
J Neurosurg; 1987 Dec; 67(6):889-94. PubMed ID: 3681427
[TBL] [Abstract][Full Text] [Related]
3. Differential retention of rhodamine 123 by avian sarcoma virus-induced glioma and normal brain tissue of the rat in vivo.
Beckman WC; Powers SK; Brown JT; Gillespie GY; Bigner DD; Camps JL
Cancer; 1987 Jan; 59(2):266-70. PubMed ID: 3026604
[TBL] [Abstract][Full Text] [Related]
4. [MCNU delivery into malignant brain tumor and normal brain tissue by intravenous or intraarterial infusion].
Miyagami M; Tazoe M; Tsubokawa T
Gan To Kagaku Ryoho; 1990 Feb; 17(2):275-80. PubMed ID: 2154161
[TBL] [Abstract][Full Text] [Related]
5. Laser photochemotherapy of rhodamine-123 sensitized human glioma cells in vitro.
Powers SK; Pribil S; Gillespie GY; Watkins PJ
J Neurosurg; 1986 Jun; 64(6):918-23. PubMed ID: 3701443
[TBL] [Abstract][Full Text] [Related]
6. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
7. Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection.
Kostron H; Bellnier DA; Lin CW; Swartz MR; Martuza RL
J Neurosurg; 1986 May; 64(5):768-74. PubMed ID: 2939204
[TBL] [Abstract][Full Text] [Related]
8. Distribution of estramustine in the BT4C rat glioma model.
Johansson M; Bergenheim AT; D'Argy R; Edman K; Gunnarsson PO; Widmark A; Henriksson R
Cancer Chemother Pharmacol; 1998; 41(4):317-25. PubMed ID: 9488601
[TBL] [Abstract][Full Text] [Related]
9. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
[TBL] [Abstract][Full Text] [Related]
10. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
11. Selective enrichment of hypericin in malignant glioma: pioneering in vivo results.
Noell S; Mayer D; Strauss WS; Tatagiba MS; Ritz R
Int J Oncol; 2011 May; 38(5):1343-8. PubMed ID: 21399870
[TBL] [Abstract][Full Text] [Related]
12. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and elimination of rhodamine 123 in the rat.
Sweatman TW; Seshadri R; Israel M
Cancer Chemother Pharmacol; 1990; 27(3):205-10. PubMed ID: 2265456
[TBL] [Abstract][Full Text] [Related]
14. Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.
Bartus RT; Snodgrass P; Marsh J; Agostino M; Perkins A; Emerich DF
J Pharmacol Exp Ther; 2000 Jun; 293(3):903-11. PubMed ID: 10869391
[TBL] [Abstract][Full Text] [Related]
15. Rhodamine-123 as a new laser dye: in vivo study of dye effects on murine metabolism, histology and ultrastructure.
Castro DJ; Saxton RE; Rodgerson DO; Fu YS; Bhuta SM; Fetterman HR; Castro DJ; Tartell PB; Ward PH
Laryngoscope; 1989 Oct; 99(10 Pt 1):1057-62. PubMed ID: 2796556
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis.
Dave N; Gudelsky GA; Desai PB
Cancer Chemother Pharmacol; 2013 Aug; 72(2):349-57. PubMed ID: 23748921
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
Kiya K; Ogasawara H; Fujita H; Sugiyama K; Kurisu K; Kawamoto K; Uozumi T; Shinkai H
Gan To Kagaku Ryoho; 1993 Apr; 20(5):631-5. PubMed ID: 8470921
[TBL] [Abstract][Full Text] [Related]
19. Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma.
Kaye AH; Morstyn G; Ashcroft RG
Neurosurgery; 1985 Dec; 17(6):883-90. PubMed ID: 2934641
[TBL] [Abstract][Full Text] [Related]
20. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]